Apr 05, 2024 04:55 AM

BUSINESS

Mitsui, Rohto to Buy Chinese Medicine Firm in $592 Million Deal

00:00

00:00/00:00

Listen to this article 1x

Singapore-based Eu Yan Sang has been in business for 145 years

Singapore-based Eu Yan Sang has been in business for 145 years

(Bloomberg) — Mitsui & Co. Ltd. and Rohto Pharmaceutical Co. Ltd. agreed to buy Eu Yan Sang International Ltd., in a deal valuing the traditional Chinese medicine company at S$800 million ($592 million).

The Japanese companies will acquire an 86% stake in Eu Yan Sang and launch a takeover bid for the remaining 14%, Mitsui said in a statement on Thursday. The acquisition is expected to close around the end of June.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Innovation Takes Off at Flying Vehicle Expo

PODCAST

Caixin Deep Dive: How China’s Crypto Ban Makes Disposing of Seized Assets a Lot Harder

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: China’s Factory Exodus Is Turning Vietnam Into the World’s Assembler

2: Meituan Enters Open-Source AI Race With LongCat Model

3: Ex-UBS Banker in Hong Kong Jailed 10 Years for Laundering $17.2 Million

4: Saudi Power Giant ACWA Bets Big on China’s Renewable Energy Market

5: End of U.S. Tax Exemption Hits Chinese Air Cargo Carriers Differently

SPONSORED

OR